LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • MoonLake Immunotherapeutics Q3 Loss Per Share $1.10 Vs Loss $0.87 Last Year 11/5/2025 7:30:51 AM
  • MoonLake Immunotherapeutics Announces Pricing Of Offering Of 7.14 Mln Class A Ordinary Shares At $10.50 11/5/2025 7:24:05 AM
  • Wedbush Is Raising MoonLake Immunotherapeutics (MLTX) FY25 Estimate To -2.84 From -3.31 5/13/2025 11:47:36 AM
  • Wedbush Is Increasing MoonLake Immunotherapeutics (MLTX) Q4 25 Estimate To -0.77 From -0.89 5/13/2025 11:47:19 AM
  • Wedbush Is Raising MoonLake Immunotherapeutics (MLTX) Q3 25 Estimate To -0.74 From -0.85 5/13/2025 11:47:08 AM
  • Wedbush Is Increasing MoonLake Immunotherapeutics (MLTX) Q2 25 Estimate To -0.70 From -0.81 5/13/2025 11:46:58 AM
  • Wedbush Reiterates MoonLake Immunotherapeutics (MLTX) At Outperform With $80 Up From $78 Price Target 5/13/2025 11:46:33 AM
  • Wedbush Is Lowering MoonLake Immunotherapeutics (MLTX) FY25 Estimate To -2.23 From -1.86 11/7/2024 5:25:45 PM
  • Wedbush Is Cutting MoonLake Immunotherapeutics (MLTX) FY24 Estimate To -1.62 From -1.33 11/7/2024 5:25:33 PM
  • Wedbush Is Lowering MoonLake Immunotherapeutics (MLTX) Q4 24 Estimate To -0.45 From -0.38 11/7/2024 5:25:23 PM
  • Wedbush Reiterates MoonLake Immunotherapeutics (MLTX) At Outperform With $73 Price Target 11/7/2024 5:24:56 PM
  • Wedbush Is Cutting MoonLake Immunotherapeutics (MLTX) FY25 Estimate To -1.86 From -0.70 11/4/2024 5:18:38 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap